On June 23, 2017, Senators Orrin Hatch (R-UT) and Ron Wyden (D-OR) and Representatives Kevin Brady (R-TX) and Richard Neal (D-MA) wrote to President Trump about “trade and investment barriers” in India. The four members of Congress are respectively the chair and ranking members of the Senate Finance and the House Ways and Means Committee.
The latest version of the USTR NAFTA renegotiation hearings schedule is out. USTR has a page for the NAFTA hearings, here, which now has the a link to the witness schedule.
There are 26 panels of witnesses over 2.5 days. Doing the math, each witness seems to have less than 10 minutes, including questions from the panel.
Attached here is the draft Trump Executive Order, titled “REDUCING THE COST OF MEDICAL PRODUCTS AND ENHANCING AMERICAN BIOMEDICAL INNOVATION,” as leaked by Politico today.
I wrote an 1800 word comment on the proposed Trump Executive Order on drug prices in medium, here. The bulk of the comment focused on the first of the “principles” and “talking points” reported by Emily Kopp in Kaiser Health News.
USTR has a request for comments on negotiating objectives for the moderation of NAFTA, docket USTR-2017-0006, and will hold a public hearing on June 27, 2017. KEI filed a set of comments and a request to testify, available here.
KEI’s comments cover an eclectic set of issues.
On June 6, 2017, Judge William Martin Conley, a United States District Judge of the United States District Court for the Western District of Wisconsin, issued a compulsory license allowing Apple Computers to use a patent it had infringed, owned by the Wisconsin Alumni Research Foundation (WARF), in return for an ongoing royally. Apple was found to infringe U.S. Patent No. 5,781,752, titled “Table based data speculation circuit for parallel processing computer. WARF asked for a permanent injunction to prevent future infringement. Continue Reading
Lexmark: The Supreme Court’s patent exhaustion case and parallel trade in drugs
KEI Briefing Note 2017:2. James Love. Revised 31 May 2017.
23 May 2017
Groups ask Army to reconsider decision that would allow French firm to charge the US anything it wants on a federally funded Zika vaccine
CONTACT: Zack Struver, zack.struver@keionline.org, +1 (914) 582-1428
Andrew Goldman, andrew.goldman@keionline.org
James Love, james.love@keionline.org, +1 (202) 361-3040
This was the KEI submission to the OECD consultation on “Sustainable access to innovative therapies,” which involved four questions posed by OECD on access to medicines.
Question 1: Reflecting on the last 5-10 years, what do you think have been the major changes affecting access to medicines?
Continue Reading